Evidence map›Paper›PMID 40630353›Full record

ArticleCureus2025

Managing Abnormal Uterine Bleeding in a Patient With Anti-Holley Antibodies and Tranexamic Acid Anaphylaxis: A Case Report.

Waseem Khan

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Waseem KhanInternal Medicine, Mercy Health St. Vincent Medical Center, Toledo, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Holley is an antigen of the Dombrock blood group system. Antibodies to Holley antigens, though extremely rare, if present, can result in hemolytic transfusion reactions. This poses a significant clinical challenge for clinicians, especially in patients who are actively bleeding and require blood transfusion. Thus, it is very important for clinicians to be aware of the presence of anti-Holley antibodies and address any management challenges while treating such patients. We report the case of a 47-year-old woman who had anti-Holley antibodies and presented with severe abnormal uterine bleeding (AUB). The patient had critical anemia with active bleeding and needed a blood transfusion, but the presence of anti-Holley antibodies made it challenging to find compatible blood for transfusion. Eventually, the patient underwent an emergency hysterectomy. To make the clinical situation further challenging, the patient developed an anaphylactic reaction to tranexamic acid. The patient was treated for anaphylaxis and subsequently stabilized. The patient was eventually discharged home in a stable condition.

Indexed as

abnormal uterine bleedinganti holley antibodiesblood transfusionholleytranexamic acid

Identifiers

PMID40630353
PMCPMC12237204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.